Responses
BASL abstracts
Viral hepatitis
P68 PACIFIC: a phase III, randomised, multicentre, dose escalation, efficacy and safety study examining the effects of treatment with peginterferon alfa-2a in patients with Child's A or B cirrhosis in chronic hepatitis C virus infection
Compose a Response to This Article
Other responses
No responses have been published for this article.